Ad26.cov2-s/elasomeran/tozinameranAnaphylaxis: 8 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1946卷 / 1期

关键词：

D O I：

10.1007/s40278-023-34618-1

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：17 / 17

相关论文

共 50 条

[21] Ad26.cov2-s/elasomeran/immune globulin/tozinameranGuillain-Barre syndrome and lack of efficacy: 10 case reports
Reactions Weekly, 2023, 1952 (1) : 26 - 26
[22] Ad26.CoV2-S/elasomeranThrombosis with thrombocytopenia syndrome: 6 case reports
Reactions Weekly, 2022, 1909 (1) : 20 - 20
[23] Ad26.COV2-S/elasomeranAcute myocardial infarction and myocarditis: 2 case reports
Reactions Weekly, 2023, 1986 (1) : 19 - 19
[24] Ad26.COV2-S/tozinameranDe novo immune thrombocytopenia: 2 case reports
Reactions Weekly, 2022, 1919 (1) : 21 - 21
[25] Ad26.COV2-S/elasomeran/tozinameranAcute kidney injury, injection-site pain and nephrotic syndrome: 6 case reports
Reactions Weekly, 2023, 1963 (1) : 19 - 19
[26] Ad26.COV2-S/tozinameranMyopericarditis and unmasking of autoimmune condition: 6 case reports
Reactions Weekly, 2022, 1933 (1) : 18 - 18
[27] Ad26.cov2-s/azd-1222/tozinameranMyocarditis: 15 case reports
Reactions Weekly, 2023, 1948 (1) : 19 - 19
[28] Ad26.COV2-S/AZD-1222Thyrotoxicosis: 7 case reports
Reactions Weekly, 2022, 1897 (1) : 19 - 19
[29] Ad26.cov2-s/elasomeranDRESS syndrome: case report
Reactions Weekly, 2022, 1927 (1) : 20 - 20
[30] Ad26.COV2-S/AZD-1222Thrombotic thrombocytopenia: 5 case reports
Reactions Weekly, 2022, 1889 (1) : 18 - 18

← 1 2 3 4 5 →